Adverum Biotechnologies Inc (NASDAQ:ADVM)
| 1.57 Delayed Data As of Jun 09 |  +0.10 / +6.80%Today’s Change | 0.53 Today|||52-Week Range 1.82 | +170.92% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -47.5M | -113.7M | -56.1M | -72.6M | |
| Depreciation | 812.0K | 1.6M | 2.1M | 1.8M | ||
| Total Other Cash Flow | 12.5M | 72.1M | 9.4M | 18.5M | ||
| Funds From Operations | -34.1M | -40.0M | -44.7M | -53.6M | ||
| Funds From/For Other Operating Expenses | 1.2M | -1.6M | 756.0K | 371.0K | ||
| Net Cash Flow - Operating Activities | -35.3M | -38.4M | -45.4M | -54.0M | ||
| Investing | Increase In Investments | -88.4M | 0.00 | -209.8M | -78.7M | |
| Decrease In Investments | 49.9M | 37.7M | 88.6M | 149.0M | ||
| Capital Expenditures | -3.0M | -2.4M | -1.0M | -809.0K | ||
| Fixed Asset Disposal | -- | 3.4M | 0.00 | -- | ||
| Net Cash Flow Investing | -41.6M | 38.8M | -122.2M | 69.4M | ||
| Financing | Short Term Borrowings | 0.00 | -- | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | -175.0K | ||
| Net Proceeds Stock Sale | 139.3M | 949.0K | 17.1M | 71.2M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | -- | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | -- | 0.00 | 0.00 | -- | |
| Other Sources - Financing | -- | 100.0K | 0.00 | 100.0K | ||
| Other Uses - Financing | 427.0K | 493.0K | 313.0K | 1.2M | ||
| Net Cash Flow - Financing | 138.9M | 556.0K | 16.7M | 69.9M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -9.0K | -143.0K | -774.0K | 0.00 | |
| Net Change In Cash | 62.0M | 965.0K | -150.9M | 85.4M | ||
